{"paper_id":"089ca43c-b2fc-4bd3-ad1f-d5bf79316c4c","body_text":"Abstract\nEndometriosis is a benign gynaecologic condition that is prevalent in the general population. Due to its high prevalence and significant impact on quality of life, endometriosis can be associated with substantial healthcare resource utilization. This problem is compounded by the propensity of patients to undergo multiple unnecessary tests and interventions across a variety of settings before obtaining an appropriate diagnosis or treatment. This is of particular concern in resource-constrained healthcare systems. Many studies have attempted to elucidate the direct and indirect costs associated with this disease to understand the societal burden of endometrosis. Study methodology and limitations in quantifying costs have made it particularly difficult to capture the entire spectrum of costs associated with endometriosis and healthcare expenditures. The economic burden of endometriosis has been previously compared to that of other chronic diseases such as diabetes and rheumatoid arthritis, demonstrating that there is growing concern around how this disease is diagnosed and managed in a manner that is cost-effective. This chapter highlights the different cost drivers and the many hidden factors that play a role in raising the global economic burden of endometriosis.\nAccess this chapter\nTax calculation will be finalised at checkout\nPurchases are for personal use only\nSimilar content being viewed by others\nReferences\nAmerican College of Obstetricians and Gynecologists. Management of endometriosis. ACOG Practice bulletin no. 114. Obstetr Gynecol. 2010;116(1):225–36.\nJohnson NP, Hummelshoj L, Adamson GD, Keckstein J, Taylor HS, Abrao MS, et al. World Endometriosis Society consensus on the classification of endometriosis. Hum Reprod. 2017;32(2):315–24.\nZondervan KT, Becker CM, Koga K, Missmer SA, Taylor RN, Viganò P. Endometriosis (Primer). Nature Reviews: Disease Primers; 2018.\nSantulli P, Marcellin L, Tosti C, Chouzenoux S, Cerles O, Borghese B, et al. MAP kinases and the inflammatory signaling cascade as targets for the treatment of endometriosis? Expert Opin Ther Targets. 2015;19(11):1465–83.\nReis FM, Santulli P, Marcellin L, Borghese B, Lafay-Pillet MC, Chapron C. Superficial peritoneal endometriosis: clinical characteristics of 203 confirmed cases and 1292 endometriosis-free controls. Reprod Sci. 2020;27(1):309–15.\nAbbas S, Ihle P, Koster I, Schubert I. Prevalence and incidence of diagnosed endometriosis and risk of endometriosis in patients with endometriosis-related symptoms: findings from a statutory health insurance- based cohort in Germany. Eur J Obstet Gynecol Reprod Biol. 2012;160:79–83.\nZondervan KT, Cardon LR, Kennedy SH. The genetic basis of endometriosis. Curr Opin Obstet Gynecol. 2001;13(3):309–14.\nMihalyi A, Mutinda KC, Simsa P, Debrock S, Mwenda JM, D'Hooghe TM. Role of immunologic and inflammatory factors in the development of endometriosis: indications for treatment strategies. Clin Pract. 2005;2(4):623.\nAdamson GD, Kennedy S, Hummelshoj L. Creating solutions in endometriosis: global collaboration through the World Endometriosis Research Foundation; 2010. p. 3–6.\nNnoaham KE, Hummelshoj L, Webster P, d’Hooghe T, de Cicco Nardone F, de Cicco Nardone C, et al. Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries. Fertil Steril. 2011;96(2):366–73.\nEskenazi B, Warner ML. Epidemiology of endometriosis. Obstet Gynecol Clin N Am. 1997;24(2):235–58.\nLouis GM, Hediger ML, Peterson CM, Croughan M, Sundaram R, Stanford J, et al. Incidence of endometriosis by study population and diagnostic method: the ENDO study. Fertil Steril. 2011;96(2):360–5.\nBarbieri RL. Etiology and epidemiology of endometriosis. Am J Obstet Gynecol. 1990;162(2):565–7.\nMeuleman C, Vandenabeele B, Fieuws S, Spiessens C, Timmerman D, D'Hooghe T. High prevalence of endometriosis in infertile women with normal ovulation and normospermic partners. Fertil Steril. 2009;92(1):68–74.\nWhitaker LH, Reid J, Choa A, McFee S, Seretny M, Wilson J, et al. An exploratory study into objective and reported characteristics of neuropathic pain in women with chronic pelvic pain. PLoS One. 2016;11(4):e0151950.\nMowers EL, Lim CS, Skinner B, Mahnert N, Kamdar N, Morgan DM, et al. Prevalence of endometriosis during abdominal or laparoscopic hysterectomy for chronic pelvic pain. Obstet Gynecol. 2016;127(6):1045–53.\nGiudice LC, Kao LC. Endometriosis. Lancet. 2004;364:1789–99.\nGao X, Outley J, Botteman M, Spalding J, Simon JA, Pashos CL. Economic burden of endometriosis. Fertil Steril. 2006;86(6):1561–72.\nGao X, Yeh YC, Outley J, Simon J, Botteman M, Spalding J. Health-related quality of life burden of women with endometriosis: a literature review. Curr Med Res Opin. 2006;22(9):1787–97.\nSurtees PG, Wainwright NW, Khaw KT, Day NE. Functional health status, chronic medical conditions and disorders of mood. Br J Psychiatry. 2003;183(4):299–303.\nFourquet J, Báez L, Figueroa M, Iriarte RI, Flores I. Quantification of the impact of endometriosis symptoms on health-related quality of life and work productivity. Fertil Steril. 2011;96(1):107–12.\nZhao SZ, Wong JM, Davis MB, Gersh GE, Johnson KE. The cost of inpatient endometriosis treatment: an analysis based on the Healthcare Cost and Utilization Project Nationwide Inpatient Sample. Am J Manag Care. 1998;4(8):1127–34.\nSenapati S, Sammel MD, Morse C, Barnhart KT. Impact of endometriosis on in vitro fertilization outcomes: an evaluation of the Society for Assisted Reproductive Technologies Database. Fertil Steril. 2016;106(1):164–71.\nLaganà AS, La Rosa VL, Rapisarda AM, Valenti G, Sapia F, Chiofalo B, et al. Anxiety and depression in patients with endometriosis: impact and management challenges. Int J Women's Health. 2017;9:323.\nFacchin F, Barbara G, Dridi D, Alberico D, Buggio L, Somigliana E, et al. Mental health in women with endometriosis: searching for predictors of psychological distress. Hum Reprod. 2017;32(9):1855–61.\nAerts L, Grangier L, Streuli I, Dällenbach P, Marci R, Wenger JM, et al. Psychosocial impact of endometriosis: From co-morbidity to intervention. Best Pract Res Clin Obstet Gynaecol. 2018;50:2–10.\nCulley L, Law C, Hudson N, Denny E, Mitchell H, Baumgarten M, et al. The social and psychological impact of endometriosis on women's lives: a critical narrative review. Hum Reprod Update. 2013;19(6):625–39.\nMoradi M, Parker M, Sneddon A, Lopez V, Ellwood D. Impact of endometriosis on women’s lives: a qualitative study. BMC Womens Health. 2014;14(1):123.\nZannoni L, Giorgi M, Spagnolo E, Montanari G, Villa G, Seracchioli R. Dysmenorrhea, absenteeism from school, and symptoms suspicious for endometriosis in adolescents. J Pediatr Adolesc Gynecol. 2014;27(5):258–65.\nSoliman AM, Coyne KS, Gries KS, Castelli-Haley J, Snabes MC, Surrey ES. The effect of endometriosis symptoms on absenteeism and presenteeism in the workplace and at home. J Manag Care Spec Pharm. 2017;23(7):745–54.\nSimoens S, Hummelshoj L, D'Hooghe T. Endometriosis: cost estimates and methodological perspective. Hum Reprod Update. 2007;13(4):395–404.\nSimoens S, Dunselman G, Dirksen C, Hummelshoj L, Bokor A, Brandes I, et al. The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres. Hum Reprod. 2012;27(5):1292–9.\nSoliman AM, Yang H, Du EX, Kelley C, Winkel C. The direct and indirect costs associated with endometriosis: a systematic literature review. Hum Reprod. 2016;31(4):712–22.\nYeung PP Jr, Shwayder J, Pasic RP. Laparoscopic management of endometriosis: comprehensive review of best evidence. J Minim Invasive Gynecol. 2009;16(3):269–81.\nLuciano AA, Lowney J, Jacobs SL. Endoscopic treatment of endometriosis-associated infertility. Therapeutic, economic and social benefits. J Reprod Med. 1992;37(7):573–6.\nMedeiros LR, Rosa DD, Bozzetti MC, Fachel JM, Furness S, Garry R, Rosa MI, Stein AT. Laparoscopy versus laparotomy for benign ovarian tumour. Cochrane Database Syst Rev. 2009;2:CD004751.\nChapron C, Cravello L, Chopin N, Kreiker G, Blanc B, Dubuisson JB. Complications during set-up procedures for laparoscopy in gynecology: open laparoscopy does not reduce the risk of major complications. Acta Obstet Gynecol Scand. 2003;82(12):1125–9.\nLing FW. Randomized controlled trial of depot leuprolide in patients with chronic pelvic pain and clinically suspected endometriosis. Obstet Gynecol. 1999;93(1):51–8.\nKennedy S, Bergqvist A, Chapron C, D'Hooghe T, Dunselman G, Greb R, et al. On behalf of the ESHRE Special Interest Group for Endometriosis and Endometrium Guideline Development Group. Hum Reprod. 2005;20(10):2698–704.\nHeim LJ. Evaluation and differential diagnosis of dyspareunia. Am Fam Physician. 2001;63(8):1535.\nBrenner PF. Differential diagnosis of abnormal uterine bleeding. Am J Obstet Gynecol. 1996;175(3):766–9.\nMounsey A, Wilgus A, Slawson DC. Diagnosis and management of endometriosis. Am Fam Physician. 2006;74(4):594–600.\nAy W. The significance of diagnostic delay in endometriosis. MOJ Womens Health. 2016;2:10–1.\nTaylor HS, Adamson GD, Diamond MP, Goldstein SR, Horne AW, Missmer SA, et al. An evidence-based approach to assessing surgical versus clinical diagnosis of symptomatic endometriosis. Int J Gynecol Obstet. 2018;142(2):131–42.\nNisenblat V, Bossuyt PM, Farquhar C, Johnson N, Hull ML. Imaging modalities for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev. 2016;2:CD009591.\nEskenazi B, Warner M, Bonsignore L, Olive D, Samuels S, Vercellini P. Validation study of nonsurgical diagnosis of endometriosis. Fertil Steril. 2001;76(5):929–35.\nLeyland N, Casper R, Laberge P, Singh SS, Allen L, Arendas K, et al. Endometriosis: diagnosis and management. J Endometr. 2010;2(3):107–34.\nPractice Committee of the American Society for Reproductive Medicine. Treatment of pelvic pain associated with endometriosis: a committee opinion. Fertil Steril. 2014;101(4):927–35.\nVercellini P, Buggio L, Frattaruolo MP, Borghi A, Dridi D, Somigliana E. Medical treatment of endometriosis-related pain. Best Pract Res Clin Obstet Gynaecol. 2018;51:68–91.\nFrishman GN, Salak JR. Conservative surgical management of endometriosis in women with pelvic pain. J Minim Invasive Gynecol. 2006;13(6):546–58.\nChiaffarino F, Cipriani S, Ricci E, Mauri PA, Esposito G, Barretta M, et al. Endometriosis and irritable bowel syndrome: a systematic review and meta-analysis. Arch Gynecol Obstet. 2020;303(1):17–25.\nBallard K, Lowton K, Wright J. What’s the delay? A qualitative study of women’s experiences of reaching a diagnosis of endometriosis. Fertil Steril. 2006;86(5):1296–301.\nPrast J, Oppelt P, Shamiyeh A, Shebl O, Brandes I, Haas D. Costs of endometriosis in Austria: a survey of direct and indirect costs. Arch Gynecol Obstet. 2013;288(3):569–76.\nMatsuzaki S, Canis M, Pouly JL, Rabischong B, Botchorishvili R, Mage G. Relationship between delay of surgical diagnosis and severity of disease in patients with symptomatic deep infiltrating endometriosis. Fertil Steril. 2006;86(5):1314–6.\nArruda MS, Petta CA, Abrão MS, Benetti-Pinto CL. Time elapsed from onset of symptoms to diagnosis of endometriosis in a cohort study of Brazilian women. Hum Reprod. 2003;18(4):756–9.\nHusby GK, Haugen RS, Moen MH. Diagnostic delay in women with pain and endometriosis. Acta Obstet Gynecol Scand. 2003;82(7):649–53.\nSoliman AM, Fuldeore M, Snabes MC. Factors associated with time to endometriosis diagnosis in the United States. J Women's Health. 2017;26(7):788–97.\nSurrey E, Soliman AM, Trenz H, Blauer-Peterson C, Sluis A. Impact of endometriosis diagnostic delays on healthcare resource utilization and costs. Adv Ther. 2020;37(3):1087–99.\nSoliman AM, Surrey ES, Bonafede M, Nelson JK, Vora JB, Agarwal SK. Health care utilization and costs associated with endometriosis among women with medicaid insurance. J Manag Care Spec Pharm. 2019;25(5):566–72.\nFuldeore M, Yang H, Du EX, Soliman AM, Wu EQ, Winkel C. Healthcare utilization and costs in women diagnosed with endometriosis before and after diagnosis: a longitudinal analysis of claims databases. Fertil Steril. 2015;103(1):163–71.\nSoliman AM, Surrey E, Bonafede M, Nelson JK, Castelli-Haley J. Real-world evaluation of direct and indirect economic burden among endometriosis patients in the United States. Adv Ther. 2018;35(3):408–23.\nMirkin D, Murphy-Barron C, Iwasaki K. Actuarial analysis of private payer administrative claims data for women with endometriosis. J Manag Care Pharm. 2007;13:262–72.\nFuldeore M, Chwalisz K, Marx S, Wu N, Boulanger L, Ma L, et al. Surgical procedures and their cost estimates among women with newly diagnosed endometriosis: a US database study. J Med Econ. 2011;14(1):115–23.\nNisenblat V, Bossuyt PM, Shaikh R, Farquhar C, Jordan V, Scheffers CS, et al. Blood biomarkers for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev. 2016;5:CD012179.\nMoore J, Copley S, Morris J, Lindsell D, Golding S, Kennedy S. A systematic review of the accuracy of ultrasound in the diagnosis of endometriosis. Ultrasound Obstetr Gynecol. 2002;20(6):630–4.\nExacoustos C, Manganaro L, Zupi E. Imaging for the evaluation of endometriosis and adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2014;28(5):655–81.\nTesta AC, Timmerman D, Van Holsbeke C, Zannoni GF, Fransis S, Moerman P, et al. Ovarian cancer arising in endometrioid cysts: ultrasound findings. Ultrasound Obstet Gynecol. 2011;38(1):99–106.\nHudelist G, English J, Thomas AE, Tinelli A, Singer CF, Keckstein J. Diagnostic accuracy of transvaginal ultrasound for non-invasive diagnosis of bowel endometriosis: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2011;37(3):257–63.\nKinkel K, Frei KA, Balleyguier C, Chapron C. Diagnosis of endometriosis with imaging: a review. Eur Radiol. 2006;16(2):285–98.\nLeonardi M, Robledo KP, Espada M, Vanza K, Condous G. SonoPODography: a new diagnostic technique for visualizing superficial endometriosis. Eur J Obstet Gynecol Reprod Biol. 2020;254:124–31.\nDmowski WP, Lesniewicz R, Rana N, Pepping P, Noursalehi M. Changing trends in the diagnosis of endometriosis: a comparative study of women with pelvic endometriosis presenting with chronic pelvic pain or infertility. Fertil Steril. 1997;67(2):238–43.\nVercellini P, Viganò P, Somigliana E, Fedele L. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014;10(5):261.\nJohnson NP, Hummelshoj L, World Endometriosis Society Montpellier Consortium, Abrao MS, Adamson GD, Allaire C, Amelung V, Andersson E, Becker C, Birna Árdal KB, Bush D. Consensus on current management of endometriosis. Hum Reprod. 2013;28(6):1552–68.\nDunselman GA, Vermeulen N, Becker C, Calhaz-Jorge C, D’Hooghe T, De Bie B, et al. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014;29(3):400–12.\nClayton RD, Hawe JA, Love JC, Wilkinson N, Garry R. Recurrent pain after hysterectomy and bilateral salpingo-oophorectomy for endometriosis: evaluation of laparoscopic excision of residual endometriosis. BJOG Int J Obstet Gynaecol. 1999;106(7):740–4.\nVercellini P, Buggio L, Berlanda N, Barbara G, Somigliana E, Bosari S. Estrogen-progestins and progestins for the management of endometriosis. Fertil Steril. 2016;106(7):1552–71.\nOlive DL, Schwartz LB. Endomeuiosis. N Engl J Med. 1993;328(24):1.\nAllaire C, Long AJ, Bedaiwy MA, Yong PJ. Interdisciplinary teams in endometriosis care. In Seminars in reproductive medicine 2020. Thieme Medical Publishers.\nBodner C, Vale L, Ratcliffe J, Farrar S. Using economics alongside medical audit. A case study of the management of endometriosis. Health Bull. 1996;54(3):204–11.\nGrand TS, Basarir H, Jackson LJ. The cost-effectiveness of oral contraceptives compared to ‘no hormonal treatment for endometriosis-related pain: An economic evaluation. PLoS One. 2019;14(1):e0210089.\nPearson S, Pickersgill A. The costs of endometriosis. InGynaecol. Forum. 2004;9:23–7.\nGuzick DS, Huang LS, Broadman BA, Nealon M, Hornstein MD. Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis-associated pelvic pain. Fertil Steril. 2011;95(5):1568–73.\nSurrey E. An economically rational method of managing early-stage endometriosis. Med Interface. 1997;10(3):119.\nLindheim SR. Chronic pelvic pain: presumptive diagnosis and therapy using GnRH agonists. Int J Fertil Womens Med. 1999;44(3):131–8.\nKephart W. Evaluation of Lovelace Health Systems chronic pelvic pain protocol. Am J Manag Care. 1999;5(5 Suppl):S309.\nArmstrong C. ACOG updates guideline on diagnosis and treatment of endometriosis. Am Fam Physician. 2011;83(1):84.\nChen I, Thavorn K, Yong PJ, Choudhry AJ, Allaire C. Hospital-associated cost of endometriosis in Canada: a population-based study. J Minim Invasive Gynecol. 2020;27(5):1178–87.\nWinkel CA. Modeling of medical and surgical treatment costs of chronic pelvic pain: new paradigms for making clinical decisions. Am J Manag Care. 1999;5(5 Suppl):S276–90.\nBedaiwy MA, Barker NM. Evidence based surgical management of endometriosis. Middle East Fertil Soc J. 2012;17(1):57–60.\nCohen MM, Young W. Costs of hysterectomy: does surgical approach make a difference? J Women's Health. 1998;7(7):885–92.\nChapron C, Fernandez B, Dubuisson JB. Total hysterectomy for benign pathologies: direct costs comparison between laparoscopic and abdominal hysterectomy. Europ J Obstetr Gynecol Reprod Biol. 2000;89(2):141–7.\nLiu H, Lu D, Wang L, et al. Robotic surgery for benign gynaecological disease. Cochrane Database Syst Rev. 2012;2:CD008978.\nKristensen SE, Mosgaard BJ, Rosendahl M, Dalsgaard T, Bjørn SF, Frøding LP, et al. Robot-assisted surgery in gynecological oncology: current status and controversies on patient benefits, cost and surgeon conditions–a systematic review. Acta Obstet Gynecol Scand. 2017;96(3):274–85.\nSoto E, Luu TH, Liu X, Magrina JF, Wasson MN, Einarsson JI, et al. Laparoscopy vs. Robotic Surgery for Endometriosis (LAROSE): a multicenter, randomized, controlled trial. Fertil Steril. 2017;107(4):996–1002.\nPache B, Joliat GR, Hübner M, Grass F, Demartines N, Mathevet P, et al. Cost-analysis of Enhanced Recovery After Surgery (ERAS) program in gynecologic surgery. Gynecol Oncol. 2019;154(2):388–93.\nSoliman AM, Taylor H, Bonafede M, Nelson JK, Castelli-Haley J. Incremental direct and indirect cost burden attributed to endometriosis surgeries in the United States. Fertil Steril. 2017;107(5):1181–90.\nMissmer SA, Cramer DW. Epidemiology of endometriosis. In Endometriosis in clinical practice 2004. CRC Press. p. 79–94.\nGuo SW. Recurrence of endometriosis and its control. Hum Reprod Update. 2009;15(4):441–61.\nVercellini P, Crosignani PG, Abbiati A, Somigliana E, Vigano P, Fedele L. The effect of surgery for symptomatic endometriosis: the other side of the story. Hum Reprod Update. 2009;15(2):177–88.\nSutton CJ, Ewen SP, Whitelaw N, Haines P. Prospective, randomized, double-blind, controlled trial of laser laparoscopy in the treatment of pelvic pain associated with minimal, mild, and moderate endometriosis. Fertil Steril. 1994;62(4):696–700.\nHornstein MD, Hemmings R, Yuzpe AA, Heinrichs WL. Use of nafarelin versus placebo after reductive laparoscopic surgery for endometriosis. Fertil Steril. 1997;68(5):860–4.\nWinkel CA. Evaluation and management of women with endometriosis. Obstet Gynecol. 2003;102(2):397–408.\nWellbery C. Diagnosis and treatment of endometriosis. Am Fam Physician. 1999;60(6):1753.\nSong JH, Lu H, Zhang J, Li B. Clinical study on the effectiveness and safety of combined laparoscopy and gonadotropin-releasing hormone agonist in the treatment of endometriosis. Zhonghua Fu Chan Ke Za Zhi. 2013;48(8):584–8. Chinese\nAlborzi S, Hamedi B, Omidvar A, Dehbashi S, Alborzi S, Alborzi M. A comparison of the effect of short-term aromatase inhibitor (letrozole) and GnRH agonist (triptorelin) versus case control on pregnancy rate and symptom and sign recurrence after laparoscopic treatment of endometriosis. Arch Gynecol Obstet. 2011;284(1):105–10.\nHornstein MD, Yuzpe AA, Burry KA, Heinrichs LR, Buttram VL Jr, Orwoll ES. Prospective randomized double-blind trial of 3 versus 6 months of nafarelin therapy for endometriosis associated pelvic pain. Fertil Steril. 1995;63(5):955–62.\nTanmahasamut P, Rattanachaiyanont M, Angsuwathana S, Techatraisak K, Indhavivadhana S, Leerasiri P. Postoperative levonorgestrel-releasing intrauterine system for pelvic endometriosis-related pain: a randomized controlled trial. Obstet Gynecol. 2012;119(3):519–26.\nChen YJ, Hsu TF, Huang BS, Tsai HW, Chang YH, Wang PH. Postoperative maintenance levonorgestrel-releasing intrauterine system and endometrioma recurrence: a randomized controlled study. Am J Obstet Gynecol. 2017;216(6):582–e1.\nShuster LT, Rhodes DJ, Gostout BS, Grossardt BR, Rocca WA. Premature menopause or early menopause: long-term health consequences. Maturitas. 2010;65(2):161–6.\nGierach GL, Pfeiffer RM, Patel DA, Black A, Schairer C, Gill A, et al. Long-term overall and disease-specific mortality associated with benign gynecologic surgery performed at different ages. Menopause (New York, NY). 2014;21(6):592.\nFaubion SS, Kuhle CL, Shuster LT, Rocca WA. Long-term health consequences of premature or early menopause and considerations for management. Climacteric. 2015;18(4):483–91.\nDuffy JM, Arambage K, Correa FJ, Olive D, Farquhar C, Garry R, et al. Laparoscopic surgery for endometriosis. Cochrane Database Syst Rev. 2014;4:CD011031.\nPractice Committee of the American Society for Reproductive Medicine. Endometriosis and infertility: a committee opinion. Fertil Steril. 2012;98(3):591–8.\nParazzini F, Di Cintio E, Chatenoud L, Moroni S, Ardovino I, Struzziero E, et al. Ablation of lesions or no treatment in minimal-mild endometriosis in infertile women: a randomized trial. Hum Reprod. 1999;14(5):1332–4.\nOsuga Y, Koga K, Tsutsumi O, Yano T, Maruyama M, Kugu K, et al. Role of laparoscopy in the treatment of endometriosis-associated infertility. Gynecol Obstet Investig. 2002;53(Suppl. 1):33–9.\nDe Ziegler D, Borghese B, Chapron C. Endometriosis and infertility: pathophysiology and management. Lancet. 2010;376(9742):730–8.\nSteures P, Van Der Steeg JW, Mol BW, Eijkemans MJ, Van Der Veen F, Habbema JD, et al. Prediction of an ongoing pregnancy after intrauterine insemination. Fertil Steril. 2004;82(1):45–51.\nEijkemans MJ, Kersten FA, Lintsen AM, Hunault CC, Bouwmans CA, Roijen L, et al. Cost-effectiveness of ‘immediate IVF’versus ‘delayed IVF’: a prospective study. Hum Reprod. 2017;32(5):999–1008.\nBenschop L, Farquhar C, van der Poel N, Heineman MJ. Interventions for women with endometrioma prior to assisted reproductive technology. Cochrane Database Syst Rev. 2010;11:CD008571.\nde Ziegler D, Gayet V, Aubriot FX, Fauque P, Streuli I, Wolf JP, et al. Use of oral contraceptives in women with endometriosis before assisted reproduction treatment improves outcomes. Fertil Steril. 2010;94(7):2796–9.\nSomigliana E, Vigano P, Benaglia L, Busnelli A, Berlanda N, Vercellini P. Management of endometriosis in the infertile patient. In Seminars in reproductive medicine 2017 (Vol. 35, No. 01, pp. 031-037). Thieme Medical Publishers.\nFerrier C, Boujenah J, Poncelet C, Chabbert-Buffet N, D’Argent EM, Carbillon L, et al. Use of the EFI score in endometriosis-associated infertility: a cost-effectiveness study. Eur J Obstetr Gynecol Reprod Biol. 2020;253:296–303.\nWinsor SP, Ala-Leppilampi K, Spitzer K, Edney DR, Petropanagos A, Cadesky KI, et al. The affordability and accessibility of Ontario’s publicly funded IVF program: a survey of patients. J Obstet Gynaecol Can. 2020;42(5):568–75.\nCollins JA. An international survey of the health economics of IVF and ICSI. Hum Reprod Update. 2002;8(3):265–77.\nSegel JE. Cost-of-illness studies—a primer. RTI-UNC Center of Excellence in Health Promotion Economics. 2006;1:39.\nKunz K, Kuppermann M, Moynihan C, Williamson A, Mazonson P. The cost of treatment of endometriosis in the California Medicaid population. Am J Managed Care. 1995;1(1):25–9.\nMathias SD, Kuppermann M, Liberman RF, Lipschutz RC, Steege JF. Chronic pelvic pain: prevalence, health-related quality of life, and economic correlates. Obstet Gynecol. 1996;87(3):321–7.\nLevy AR, Osenenko KM, Lozano-Ortega G, Sambrook R, Jeddi M, Bélisle S, et al. Economic burden of surgically confirmed endometriosis in Canada. J Obstet Gynaecol Can. 2011;33(8):830–7.\nDenny E. Women's experience of endometriosis. J Adv Nurs. 2004;46(6):641–8.\nSperschneider ML, Hengartner MP, Kohl-Schwartz A, Geraedts K, Rauchfuss M, Woelfler MM, et al. Does endometriosis affect professional life? A matched case-control study in Switzerland, Germany and Austria. BMJ Open. 2019;9(1):e019570.\nEstes SJ, Soliman AM, Yang H, Wang J, Freimark J. A longitudinal assessment of the impact of endometriosis on patients’ salary growth and risk of leaving the workforce. Adv Ther. 2020;37(5):2144–58.\nSimoens S, Meuleman C, D’Hooghe T. Non-health-care costs associated with endometriosis. Hum Reprod. 2011;26(9):2363–7.\nOppelt P, Chavtal R, Haas D, Reichert B, Wagner S, Müller A, et al. Costs of in-patient treatment for endometriosis in Germany 2006: an analysis based on the G-DRG-Coding. Gynecol Endocrinol. 2012;28(11):903–5.\nTaipale K, Leminen A, Räsänen P, Heikkilä A, Tapper AM, Sintonen H, et al. Costs and health-related quality of life effects of hysterectomy in patients with benign uterine disorders. Acta Obstet Gynecol Scand. 2009;88(12):1402–10.\nKlein S, D’Hooghe T, Meuleman C, Dirksen C, Dunselman G, Simoens S. What is the societal burden of endometriosis-associated symptoms? A prospective Belgian study. Reprod Biomed Online. 2014;28(1):116–24.\nVercellini P, Giudice LC, Evers JL, Abrao MS. Reducing low-value care in endometriosis between limited evidence and unresolved issues: a proposal. Hum Reprod. 2015;30(9):1996–2004.\nAuthor information\nAuthors and Affiliations\nCorresponding author\nEditor information\nEditors and Affiliations\nRights and permissions\nCopyright information\n© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG\nAbout this chapter\nCite this chapter\nSivajohan, B., Lin, T., Bedaiwy, M.A. (2022). Cost Estimates Associated with Diagnosis and Treatment of Endometriosis. In: Oral, E. (eds) Endometriosis and Adenomyosis. Springer, Cham. https://doi.org/10.1007/978-3-030-97236-3_28\nDownload citation\nDOI: https://doi.org/10.1007/978-3-030-97236-3_28\nPublished:\nPublisher Name: Springer, Cham\nPrint ISBN: 978-3-030-97235-6\nOnline ISBN: 978-3-030-97236-3\neBook Packages: MedicineMedicine (R0)","source_license":"CC0","license_restricted":false}